1-9 of 9
Keywords: Gilbert's syndrome
Close
Follow your search
Access your saved searches in your account

Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Articles
Clin Sci (Lond) (2015) 129 (1): 1–25.
Published: 01 April 2015
...@cesnet.cz ). 29 9 2014 13 1 2015 2 2 2015 © The Authors Journal compilation © 2015 Biochemical Society 2015 all-cause mortality bile pigment bilirubin biomarker cancer cardiovascular disease chronic disease Gilbert's syndrome The formation, metabolism and...
Articles
Clin Sci (Lond) (2013) 125 (5): 257–264.
Published: 10 May 2013
...Marlies Wallner; Rodrig Marculescu; Daniel Doberer; Michael Wolzt; Oswald Wagner; Libor Vitek; Andrew C. Bulmer; Karl-Heinz Wagner Recent epidemiological and clinical data show protection from CVD (cardiovascular disease), all-cause mortality and cancer in subjects with GS (Gilbert's syndrome...
Includes: Supplementary data
Articles
Clin Sci (Lond) (1985) 68 (6): 675–680.
Published: 01 June 1985
... subjects with Gilbert's syndrome and 35 control subjects of both sexes. 2. Both the plasma disappearance rate and the unconjugated hyperbilirubinaemia after RSV administration were higher ( P <0.001) in Gilbert's syndrome. Females, both normal and with the syndrome, showed a significantly shorter t 1/2...
Articles
Clin Sci (Lond) (1984) 66 (4): 493–496.
Published: 01 April 1984
... effect of caloric restriction alone. 2. In normal individuals ( n = 10) the rise of plasma bilirubin was comparable after the two trials. In patients with Gilbert's syndrome ( n = 18), bilirubin concentration rose to a much greater extent during the caloric restriction as compared with controls, and to a...
Articles
Clin Sci (Lond) (1984) 66 (4): 389–397.
Published: 01 April 1984
...Klaus Kutz; Harald Kandler; Roland Gugler; Johan Fevery 1. Clofibrate (20 mg day −1 kg −1 body weight) given orally for 2 weeks to 18 subjects with Gilbert's syndrome reduced the total serum bilirubin concentration from 44.4 (22.1–71.7) μmol/l (median, range) to 15.0 (7.9–28.9) μmol/l, mainly by...
Articles
Clin Sci (Lond) (1982) 62 (6): 643–649.
Published: 01 June 1982
...M. L. Zeneroli; V. Piaggi; C. Cremonini; C. Gozzi; E. Ventura 1. The kinetics of non-radioactive bilirubin were investigated in 100 patients with chronic non-haemolytic unconjugated hyperbilirubinaemia and in nine normal volunteers. 2. The patients with Gilbert's syndrome were divided on the basis...
Articles
Clin Sci Mol Med (1978) 55 (1): 63–71.
Published: 01 July 1978
...C. A. Goresky; Ellen R. Gordon; E. A. Shaffer; P. Paré; D. Carassavas; A. Aronoff 1. Intravenous doses of bilirubin (3.4 μmol/kg) were given to normal subjects and patients with Gilbert's syndrome. Both groups displayed an identical initial disappearance of a substantial proportion of the bilirubin...
Articles
Clin Sci Mol Med (1978) 54 (5): 539–547.
Published: 01 May 1978
...L. Okolicsanyi; O. Ghidini; R. Orlando; S. Cortelazzo; G. Benedetti; R. Naccarato; P. Manitto 1. The kinetics of the plasma disappearance of bilirubin (2 mg/kg intravenously) were studied in 106 patients with Gilbert's syndrome and in 13 normal subjects. 2. All patients had significant decreases in...
Articles
Clin Sci Mol Med (1974) 46 (1): 1–17.
Published: 01 January 1974
...M. Black; J. Fevery; D. Parker; J. Jacobson; Barbara H. Billing; E. R. Carson 1. The clearance of a tracer dose of [ 14 C]bilirubin from the plasma was studied in patients with Gilbert's syndrome, congenital non-haemolytic jaundice, haemolytic jaundice and in normal subjects. Clearance was...